公司資料
Incannex Healthcare 股價、新聞與催化劑
- 股票代碼:
- IXHL
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Australia and listed in the U
股票表現
3.31 USD (+1.07%)
收盤價
最後更新: 2026年8月17日
36.5M USD
市值
股價為何變動
As of Aug 17, 2026, IXHL closed up 1.07% at $3.31. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Incannex Healthcare is a biotechnology company focused on cannabinoid-based and related therapies for inflammatory and sleep disorders. Its story is centered on translating cannabinoid science into specialty treatments.
所在地與產業分類
Incannex is headquartered in Australia and listed in the U.S. market. It sits in specialty biotechnology with a cannabinoid and inflammation focus.
商業模式特徵
The company depends on clinical data, regulatory progress, and capital efficiency while it develops a narrow pipeline. Investors watch early signals and commercialization potential.
生技產業定位
Incannex occupies a niche cannabinoid-biotech position. The stock is catalyst-sensitive because the company still needs to prove its therapeutic thesis in the clinic.
未來催化劑
- Incannex’s catalysts are its cannabinoid / inflammatory-disease programs and any clinical step that keeps the platform alive. The stock remains highly event-driven.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。